Large Molecule Bioanalytical Technologies Market To Reach $16.76 Billion By 2030

Large Molecule Bioanalytical Technologies Market Growth & Trends

The global large molecule bioanalytical technologies market size is estimated to reach USD 16.76 billion by 2030, registering a CAGR of 10.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

 Request a free sample copy or view report summary: Large Molecule Bioanalytical Technologies Market Report

Large Molecule Bioanalytical Technologies Market Report Highlights

• In 2024, the product segment dominated the market with the largest revenue share of 71.5%, propelled by the growing demand for advanced tools and instruments used in the analysis of biologics.

• Based on application, the biologics segment secured the largest revenue share in 2024, due to the rapid growth of biologics, including monoclonal antibodies, gene therapies, and biosimilars.

• The cell and gene therapy application segment is expected to grow at the fastest CAGR during the forecast period.

• In 2024, North America held the largest revenue share of 34.2% in the global market, driven by the rising trend of regenerative medicine and the growing focus on cancer and rare diseases.

• Asia Pacific is anticipated to be the fastest-growing region with a CAGR of 11.7% over the forecast 

Large Molecule Bioanalytical Technologies Market Segmentation

Grand View Research has segmented the global large molecule bioanalytical technologies market on the basis of products & services, application, and region:

Large Molecule Bioanalytical Technologies Products & Services Outlook (Revenue, USD Million, 2018 - 2030)

• Product

  • Consumables & Accessories

  • Instruments

  • Reagents & Kits

• Service

Large Molecule Bioanalytical Technologies Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biologics 

• Oligonucleotide Derived Drugs & Molecules

• Viral Vector

• Cell & Gene Therapy

• Nanoparticles & Polymers

Large Molecule Bioanalytical Technologies Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Large Molecule Bioanalytical Technologies Market

• Intertek Group plc

• Solvias

• Bio-Techne

• Waters Corporation

• Cytiva

• Verder Scientific GmbH & Co. KG

• Halo Labs

• Charles River Laboratories

• Avomeen

• Merck KGaA

• Cergentis B.V.

• Labcorp

• SCIEX

• F. Hoffmann-La Roche Ltd

• Bio-Rad Laboratories, Inc.